Login
$IMUX
$7.23 -$0.29 (3.86%) Live

$IMUX 8-K/A SEC Filings

Filed On Filing
04 Aug 2022 8-K/A: Other Events

On August 4, 2022, the Company posted an updated corporate presentation on its website at imux.com and filed the presentation as Exhibit 99.2 to the Original 8-K. This Amendment No. 1 to Current Report on Form 8-K/A is being filed to cor...

13 Nov 2020 8-K/A: Entry into a Material Definitive Agreement

Reference is made to the Securities Purchase Agreement dated April 23, 2020 (the “Purchase Agreement”) between Immunic, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages thereto (each, inc...

01 Apr 2016 8-K/A: Departure/Election of Directors or Officers; Compensation

On July 16, 2015, Vital Therapies, Inc. (the “Company”) filed a Current Report on Form 8-K announcing the appointment of Cheryl L. Cohen to the Company’s Board of Directors (the “Board”) on July 14, 2015. At that time, Ms. Cohen had not ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support